382 related articles for article (PubMed ID: 22834199)
1. Cancer stem cell targeting: the next generation of cancer therapy and molecular imaging.
Shigdar S; Lin J; Li Y; Yang CJ; Wei M; Zhus Y; Liu H; Duan W
Ther Deliv; 2012 Feb; 3(2):227-44. PubMed ID: 22834199
[TBL] [Abstract][Full Text] [Related]
2. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of epithelial-mesenchymal transition and cancer stem cells.
Topcul M; Cetin I
J BUON; 2016; 21(2):312-9. PubMed ID: 27273939
[TBL] [Abstract][Full Text] [Related]
4. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
5. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
6. The bad seed: Cancer stem cells in tumor development and resistance.
Koren E; Fuchs Y
Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
[TBL] [Abstract][Full Text] [Related]
7. Cancer stem cell (CSC) resistance drivers.
Najafi M; Mortezaee K; Majidpoor J
Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
[TBL] [Abstract][Full Text] [Related]
8. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
[TBL] [Abstract][Full Text] [Related]
9. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Effectiveness of Anticancer Phytochemicals on Cancer Stem Cells.
Oh J; Hlatky L; Jeong YS; Kim D
Toxins (Basel); 2016 Jun; 8(7):. PubMed ID: 27376325
[TBL] [Abstract][Full Text] [Related]
11. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.
Clara JA; Monge C; Yang Y; Takebe N
Nat Rev Clin Oncol; 2020 Apr; 17(4):204-232. PubMed ID: 31792354
[TBL] [Abstract][Full Text] [Related]
12. Cancer Stem Cells in Prostate Cancer: Implications for Targeted Therapy.
Leão R; Domingos C; Figueiredo A; Hamilton R; Tabori U; Castelo-Branco P
Urol Int; 2017; 99(2):125-136. PubMed ID: 28142149
[TBL] [Abstract][Full Text] [Related]
13. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic approaches targeting cancer stem cells.
Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells - A therapeutic target?
Maitland NJ; Collins AT
Curr Opin Mol Ther; 2010 Dec; 12(6):662-73. PubMed ID: 21154158
[TBL] [Abstract][Full Text] [Related]
16. Targeting Cancer Stemness in the Clinic: From Hype to Hope.
Saygin C; Matei D; Majeti R; Reizes O; Lathia JD
Cell Stem Cell; 2019 Jan; 24(1):25-40. PubMed ID: 30595497
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cell characteristics and their potential as therapeutic targets.
Lim JR; Mouawad J; Gorton OK; Bubb WA; Kwan AH
Med Oncol; 2021 May; 38(7):76. PubMed ID: 34050825
[TBL] [Abstract][Full Text] [Related]
18. Designing precision medicine panels for drug refractory cancers targeting cancer stemness traits.
Warrier S; Patil M; Bhansali S; Varier L; Sethi G
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188475. PubMed ID: 33188876
[TBL] [Abstract][Full Text] [Related]
19. Tumor-infiltrating macrophages, cancer stem cells and therapeutic responses.
Panni RZ; Linehan DC; Denardo DG
Oncotarget; 2012 Dec; 3(12):1497-8. PubMed ID: 23455077
[No Abstract] [Full Text] [Related]
20. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]